A Contemporary Analysis of Surgical Trends in the Treatment of Squamous Cell Carcinoma of the Oropharynx from 1998 to 2012: A Report from the National Cancer Database

Annals of Surgical Oncology

Volumn 22, Issue 13, 2015, Pages 4422-4431

  Liederbach, Erik ^a   Lewis, Carol M ^b   Yao, Katharine ^a,c   Brockstein, Bruce E ^a,c   Wang, Chi Hsiung ^a   Lutfi, Waseem ^a   Bhayani, Mihir K ^a,c  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLACK PERSON; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GEOGRAPHY; HISPANIC; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; OROPHARYNX CARCINOMA; OROPHARYNX SQUAMOUS CELL CARCINOMA; PATIENT SELECTION; RACE; ROBOT ASSISTED SURGERY; SOCIAL STATUS; TREND STUDY; UNITED STATES; WART VIRUS; ADOLESCENT; CARCINOMA, SQUAMOUS CELL; FACTUAL DATABASE; FOLLOW UP; MIDDLE AGED; MORTALITY; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PHARYNGECTOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURVIVAL RATE; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PHARYNGECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84947125536     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4560-x     Document Type: Article

References (44)

1. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers Version 2.2014. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed 20 Mar 2015.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.
3. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.
4. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94:2967–80.
5. Chen AY, Zhu J, Fedewa S. Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009. Laryngoscope. 2014;124:131–8.
6. Bhayani MK, Holsinger FC, Lai SY. A shifting paradigm for patients with head and neck cancer: transoral robotic surgery (TORS). Oncology Williston Park. 2010;24:1010–5.
7. Hurtuk AM, Marcinow A, Agrawal A, et al. Quality-of-life outcomes in transoral robotic surgery. Otolaryngol Head Neck Surg. 2012;146:68–73.
8. Hutcheson KA, Holsinger FC, Kupferman ME. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol. 2015;272:463–71.
9. The United States Food and Drug Administration: 501(k) summary, section III: indications for use for Intuitive Surgical endoscopic instrument control system. http://www.accessdata.fda.gov/cdrh_docs/pdf9/K090993.pdf. Accessed 20 Mar 2015.
10. Bilimoria K, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683–90.
11. Bilimoria KY, Bentrem DJ, Stewart AK, et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27:4177–81.
12. US Census: Statistical Groupings of States and Counties. http://www.census.gov/geo/reference/pdfs/GARM/Ch6GARM.pdf. Accessed 20 Mar 2015.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.
14. Edge SB, Compton CC; The American Joint Committee on Cancer. The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.
15. Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope. 2007;117:16–21.
16. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–9.
17. Hutcheson KA, Lewin JS, Barringer DA, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer. 2012;118:5793–9.
18. Holsinger FC, McWhorter AJ, Menard M, et al. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg. 2005;131:583–91.
19. Hockstein NG, O’Malley BW Jr, Weinstein GS. Assessment of intraoperative safety in transoral robotic surgery. Laryngoscope. 2006;116:165–8.
20. Chen MM, Roman SA, Kraus DH, et al. Transoral robotic surgery: a population-level analysis. Otolaryngol Head Neck Surg. 2014;150:968–75.
21. Kim SP, Boorjian SA, Shah ND, et al. Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy. J Urol. 2013;189: 514–20.
22. Forde GK, Chang J, Liu F, et al. Disparities in access to minimally invasive surgery for women undergoing hysterectomy in california. Obstet Gynecol. 2014;123(Suppl 1):28S.
23. Shavers VL, Harlan LC, Winn D, et al. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003;22:25–38.
24. Weng Y, Korte JE. Racial disparities in being recommended to surgery for oral and oropharyngeal cancer in the United States. Community Dent Oral Epidemiol. 2012;40:80–8.
25. Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–205.
26. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006;24:413–8.
27. Cykert S, Dilworth-Anderson P, Monroe MH, et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA. 2010; 303:2368–76.
28. Fillion L, de Serres M, Cook S, et al. Professional patient navigation in head and neck cancer. Semin Oncol Nurs. 2009;25:212–21.
29. Richmon JD, Agrawal N, Pattani KM. Implementation of a TORS program in an academic medical center. Laryngoscope. 2011;121:2344–8.
30. Modest MC, Galinat L, Rabinowitz MR, et al. Learning progression in the use of sialendoscopy for sialolithiasis: effect on gland preservation. Otolaryngol Head Neck Surg. 2014;151:240–5.
31. White HN, Frederick J, Zimmerman T, et al. Learning curve for transoral robotic surgery: a 4-year analysis. JAMA Otolaryngol Head Neck Surg. 2013;139:564–7.
32. Chen MM, Roman SA, Yarbrough WG, et al. Trends and variations in the use of adjuvant therapy for patients with head and neck cancer. Cancer. 2014;120:3353–60.
33. Voti L, Richardson LC, Reis IM, et al. Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer. 2006;106:201–7.
34. Schroen AT, Brenin DR, Kelly MD, et al. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005;23:7074–80.
35. Celaya MO, Rees JR, Gibson JJ, et al. Travel distance and season of diagnosis affect treatment choices for women with early-stage breast cancer in a predominantly rural population (United States). Cancer Causes Control. 2006;17:851–6.
36. Seifer SD, Vranizan K, Grumbach K. Graduate medical education and physician practice location: implications for physician workforce policy. JAMA. 1995;274:685–91.
37. Steele SR, Stein SL, Bordeianou LG, et al. The impact of practice environment on laparoscopic colectomy utilization following colorectal residency: a survey of the ASCRS Young Surgeons. Colorectal Dis. 2012;14:374–81.
38. Dartmouth Institute for Health Policy and Clinical Practice. Hanover (NH): Dartmouth Institute. Dartmouth atlas of health care.http://www.dartmouthatlas.org. Accessed 31 Mar 2010.
39. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–9.
40. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res Philadelphia. 2009;2:776–81.
41. In H, Bilimoria KY, Stewart AK, et al. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014;21:1520–9.
42. Holsinger FC. Randomized phase II trial of transoral endoscopic head and neck surgery followed by risk-based IMRT and weekly cisplatin versus IMRT and weekly cisplatin for HPV-negative oropharynx cancer. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1221. Accessed 20 Mar 2015.
43. Ferris RL. Phase II randomized trial of transoral surgical resection followed by low-dose or standard-dose IMRT in resectable p16 positive locally advanced oropharynx cancer. http://ecog-acrin.org/trials/head-and-neck. Accessed 20 Mar 2015.
44. Lewis CM, Weber RS. Standardizing treatment: a crisis in cancer care. Otolaryngol Clin North Am. 2013;46:671–9.